ProQR Therapeutics (PRQR) Other Operating Expenses (2014 - 2025)

ProQR Therapeutics' Other Operating Expenses history runs 9 years deep, the most recent figure standing at $0.0 for Q1 2025.

• In Q1 2025, Other Operating Expenses changed N/A year-over-year to $0.0; the TTM figure through Dec 2025 stood at $0.0 (up 111.11% YoY), while the FY2025 annual figure was -$3.1 million, down 6.64% from the prior year.
• Other Operating Expenses came in at $0.0 for Q1 2025 at ProQR Therapeutics, up from -$0.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $0.0 in Q4 2023 to a low of -$0.0 in Q4 2024.
• A 5-year average of $0.0 and a median of $0.0 in 2021 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses tumbled 300.0% in 2022 and tumbled 200.0% in 2024, its largest moves.
• ProQR Therapeutics' Other Operating Expenses stood at $0.0 in 2021, then jumped by 100.0% to $0.0 in 2022, then soared by 300.0% to $0.0 in 2023, then sank by 200.0% to -$0.0 in 2024, then surged by 112.5% to $0.0 in 2025.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $0.0, -$0.0, and -$0.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison